The Lancet: Plastic pollution is an underrecognised threat to health, experts warn as they launch a project to track plastics’ health impacts and monitor progress
Peer-Reviewed Publication
Updates every hour. Last Updated: 12-Aug-2025 05:11 ET (12-Aug-2025 09:11 GMT/UTC)
Reaching the age of 100 does not necessarily mean a life fraught with illness. A new study from Karolinska Institutet shows that centenarians not only live longer, they also stay healthier than other older people, with fewer diseases that develop more slowly.
Cannabis use is gaining popularity in the United States, driven by growing legalization, public acceptance and diverse methods of consumption.
More people than ever before support its legal medicinal and recreational use, and more adults — mainly men — are turning to cannabis for relief from physical and mental health symptoms.
Now, health behavior experts from the Texas A&M University School of Public Health, along with collaborators from three other universities, have taken a closer look at this dual use among Hispanic and non-Hispanic Black men living with chronic health conditions.
In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights into how a critical brain receptor works at the molecular level and why that matters for mental health treatments. The study, published in the August 1 online issue of Science Advances, focuses on the 5-HT1A serotonin receptor, a major player in regulating mood and a common target of both traditional antidepressants and newer therapies such as psychedelics. Despite its clinical importance, this receptor has remained poorly understood, with many of its molecular and pharmacological properties largely understudied—until now.
An analysis published today in The Journal of Clinical Investigation explains how leptin affects the brain and how it might be used in future therapeutics.
DKA happens when the body is unable to make insulin and begins to break down fat for fuel. This can lead to a life-threatening buildup of sugar (glucose) and ketoacids in the blood. Doctors have typically administered insulin to address the complication, authors noted.
But evidence now shows that, when insulin is insufficient, the brain plays a key role in driving DKA, according to the new analysis, based in literature and research that includes studies conducted at UW Medicine since 2011.